INTRODUCTION
Wilms' Tumour (Nephroblastoma) is an embryonal tumour of the kidney, which affects approximately 1 in 10,000 children and accounts for 6% of all paediatric cancers. Although the vast majority of Wilms' tumours are sporadic, in the small percentage of hereditary cases (4-8%) observed, the tumour is often bilateral and arises at an early age. Furthermore, a genetic predisposition to develop the tumour is associated with aniridia, genitourinary abnormalities and mental retardation (the WAGR syndrome) (1) . Children with this rare syndrome typically carry a germline deletion involving band p13 on one of the two (parentally-derived) chromosome 11 homologues (2) . The inherited 11 p deletion in WAGR and hereditary Wilms' patients is thought to represent the first of two events required for initiation of Wilms' tumour, as postulated by Knudson from epidemiological studies (3) . In addition, the specific loss of chromosome lip alleles has been shown in sporadic Wilms' tumours (4) (5) (6) (7) . This Fig. 1 B-globin and c-Ha-ras-1 (see Fig. 2 Fig. 1 (b) ). This variable and regional lip gene amplification in DNA derived from normal kidney tissues adjacent to Wilms' tumour may be of great importance.
It has been argued that a spontaneous degree of overreplication does occur in non-tumourigenic normal cells (14) . There is evidence that preferred chromosomal regions for amplification of genes exist and possibly 11 p Fig. 2 (c) was re-hybridized with these probes (e.g.vVI catalase in Fig. 2 (f) 
